Immunohistochemistry staining for γH2AX revealed a significantly higher percentage of γH2AX-positive tumor cells in PARPi-treated FANCA-deficient tumors, implicating DNA damage accumulation as a likely driver of tumor cell synthetic lethality (Fig. 1l). This evidence concerns the gene FANCA and neoplasm.